Title : New therapeutic options in systemic treatment of advanced cutaneous melanoma.

Pub. Date : 2013 Feb

PMID : 23215674






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 EXPERT OPINION: Elucidation of the crucial role of MAPK pathway and BRAF kinase mutations in particular has led to development of specific small molecule kinase inhibitors (vemurafenib, dabrafenib, trametinib), and new insight into molecular mechanisms responsible for immune response and tolerance resulted in development of immunomodulatory agents (ipilimumab, anti-PD1, anti-PD-L1). Vemurafenib CD274 molecule Homo sapiens
2 EXPERT OPINION: Elucidation of the crucial role of MAPK pathway and BRAF kinase mutations in particular has led to development of specific small molecule kinase inhibitors (vemurafenib, dabrafenib, trametinib), and new insight into molecular mechanisms responsible for immune response and tolerance resulted in development of immunomodulatory agents (ipilimumab, anti-PD1, anti-PD-L1). dabrafenib CD274 molecule Homo sapiens